Form 8-K - Current report:
SEC Accession No. 0001104659-23-050387
Filing Date
2023-04-26
Accepted
2023-04-26 16:30:59
Documents
12
Period of Report
2023-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2313829d1_8k.htm   iXBRL 8-K 32250
  Complete submission text file 0001104659-23-050387.txt   199913

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bnkl-20230420.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bnkl-20230420_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bnkl-20230420_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2313829d1_8k_htm.xml XML 3172
Mailing Address 80 COOLIDGE HILL ROAD WATERTOWN MA 02472
Business Address 80 COOLIDGE HILL ROAD WATERTOWN MA 02472 1-617-926-4800
Bionik Laboratories Corp. (Filer) CIK: 0001508381 (see all company filings)

IRS No.: 271340346 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-54717 | Film No.: 23850217
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies